Literature DB >> 32578540

Concept for Visualisation of Guideline Adherence of Medication Prescriptions in a Heart Failure Telehealth System.

Aaron Lauschensky1,2, Dieter Hayn1, Alphons Eggerth1,2, Robert Modre-Osprian1, Bernhard Pfeifer1,3, Tim Egelseer-Bründl3, Gerhard Pölzl4, Günter Schreier1,2.   

Abstract

BACKGROUND: Heart failure is a chronic disease that affects around 26 million people worldwide. Projections assume a substantial increase in prevalence over the next years. To improve the survival rate and quality of life in patients suffering from heart failure, the European Society of Cardiology published guidelines for diagnosis and treatment. Adherence of healthcare professionals' medication prescriptions with regard to these guidelines is critical for optimal outcomes.
METHODS: Data from the conceptional phase of the existing disease management network 'HerzMobil Tirol' were analysed. Prescriptions and patient- reported intake data of the four major substances of recommended heart failure medication were used to calculate the relative prescribed doses as a percentage of the recommended target doses. A concept for visualisation of the prescription status was developed in cooperation with health professionals.
RESULTS: The documented prescriptions were analysed and used to develop a mock-up in order to visualise the prescription status for the individual patient.
CONCLUSION: Analysis and visualisation can be managed by displaying the calculated daily relative dose per substance group in a traffic light system.

Entities:  

Keywords:  guideline; heart failure; medication adherence; prescriptions; telemedicine

Year:  2020        PMID: 32578540     DOI: 10.3233/SHTI200073

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  1 in total

1.  Feasibility and effectiveness of a multidimensional post-discharge disease management programme for heart failure patients in clinical practice: the HerzMobil Tirol programme.

Authors:  G Poelzl; T Egelseer-Bruendl; B Pfeifer; R Modre-Osprian; S Welte; B Fetz; S Krestan; B Haselwanter; M M Zaruba; J Doerler; C Rissbacher; E Ammenwerth; A Bauer
Journal:  Clin Res Cardiol       Date:  2021-07-16       Impact factor: 5.460

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.